Aflibercept Ophthalmic Dosage

This dosage information may not include all the information needed to use Aflibercept Ophthalmic safely and effectively. See additional information for Aflibercept Ophthalmic.

The information at is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Additional dosage information:

Usual Adult Dose for Macular Degeneration

Neovascular (Wet) Age Related Macular Degeneration (AMD):

2 mg (0.05 mL) administered by intravitreal injection every 4 weeks (monthly) for the first 3 months, followed by 2 mg (0.05 mL) via intravitreal injection once every 8 weeks (2 months).


Usual Adult Dose for Macular Edema

Macular edema following central retinal vein occlusion (CRVO):

2 mg (0.05 ml) administered by intravitreal injection once every 4 weeks.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available


Safety and effectiveness have not been established in pediatric patients (less than 18 years of age).


Data not available